Psychedelic combo tested for safety in small human study

NCT ID NCT07079930

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study will give 10 healthy adults a single dose of psilocybin (the active ingredient in magic mushrooms) combined with D-serine, an amino acid. Researchers want to see if D-serine can tone down the psychedelic effects and improve safety. The goal is to find the right dose for future trials, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

psilocybin and D-serine

What this could lead to

If successful, this could help determine a safe dose for future studies exploring psilocybin's effects when combined with D-serine.

What could go wrong

This is a very early, small Phase 1 trial in only 10 healthy volunteers. It is designed to test safety, not effectiveness, and may not lead to any treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hadassah Medical Organization, Jerusalem, Israel

    RECRUITING

    Jerusalem, Israel

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••